Adverum Biotechnologies, Inc.
ADVM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$130,927 | -$122,116 | -$154,536 | -$145,540 |
| Dep. & Amort. | $3,653 | $5,644 | $6,528 | $4,645 |
| Deferred Tax | $0 | $0 | $0 | $3,833 |
| Stock-Based Comp. | $14,350 | $17,569 | $20,079 | $25,194 |
| Change in WC | $911 | -$8,507 | $19,889 | $4,062 |
| Other Non-Cash | $19,551 | $16,508 | -$51 | -$25 |
| Operating Cash Flow | -$92,462 | -$90,902 | -$108,091 | -$107,831 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$388 | -$808 | -$11,816 | -$15,123 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$101,901 | -$36,718 | -$104,363 | -$407,514 |
| Inv. Sales/Matur. | $60,400 | $134,401 | $257,899 | $501,346 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$41,889 | $96,875 | $141,720 | $78,709 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$240 |
| Stock Issued | $119,361 | $489 | $607 | $1,685 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $642 | -$420 | $0 | $952 |
| Financing Cash Flow | $120,003 | $69 | $607 | $2,397 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$14,348 | $6,042 | $34,236 | -$26,725 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $76,976 | $70,934 | $36,698 | $63,423 |
| End Cash | $62,628 | $76,976 | $70,934 | $36,698 |
| Free Cash Flow | -$92,850 | -$91,710 | -$119,907 | -$122,954 |